fbpx
01 / 05
Introducing Our Upcoming Book, Heroes of Progress

Blog Post | Science & Education

Introducing Our Upcoming Book, Heroes of Progress

Over the past two centuries, humanity has become massively more prosperous, better educated, healthier, and more peaceful.

The underlying cause of this progress is innovation. Human innovation―whether it be new ideas, inventions, or systems―is the primary way people create wealth and escape poverty.

Our upcoming book, Heroes of Progress: 65 People Who Changed the World, explores the lives of the most important innovators who have ever lived, from agronomists who saved billions from starvation and intellectuals who changed public policy for the better, to businesspeople whose innovations helped millions rise from poverty.

If it weren’t for the heroes profiled in this book, we’d all be far poorer, sicker, hungrier, and less free―if we were fortunate enough to be alive at all.

Considering their impact on humanity, perhaps it’s time to learn their story?

Heroes of Progress book advertised on Amazon for pre-order

Heroes of Progress Book Forum

On March 21st, the author of Heroes of Progress, Alexander Hammond, will present the book live at the Cato Institute in Washington, D.C. He will be joined by Marian Tupy, the editor of Human Progress, and Clay Routledge, the Archbridge Institute’s Vice President of Research, who will speak on the individual’s role in advancing human progress and the need for a cultural progress movement.

Learn more about the event here.

Praise for Heroes of Progress

Making an inspiring case for progress at this time of skepticism and historical ingratitude is no easy feat. Yet, by relentlessly outlining the extraordinary ability of individuals to shape our world for the better, Alexander Hammond does just that.

Steven Pinker, author of Enlightenment Now: The Case for Reason, Science, Humanism, and Progress

Innovation is a team sport achieved by people working together, using precious freedoms to change the world, so it’s sometimes invidious to single out one person for credit. But once an idea is ripe for plucking, the right person at the right time can seize it and save a million lives or open a million possibilities. Each of these 65 people did that, and their stories are both thrilling and beautiful.

Matt Ridley, author of How Innovation Works: And Why It Flourishes in Freedom

The figures in this book are the overlooked and often unknown figures who have transformed the lives of ordinary people, for the better… This book is a correction to widespread pessimism and is both informative and inspirational.

Dr. Stephen Davies, author of The Wealth Explosion: The Nature and Origins of Modernity

Superman and the Avengers are all very well, of course, but the real superheroes are thinkers, scientists, and innovators of flesh and blood who saved us from a life that used to be poor, nasty, brutish, and short. Alexander Hammond tells their inspiring stories in this magnificent book that will leave you grateful to be living in the world these men and women created.

— Johan Norberg, author of Open: The Story of Human Progress

The 65 innovators honored here made us happier, healthier, and longer-lived. Indeed, it is thanks to some of them that we are here at all. Their story is the story of how the human race acquired powers once attributed to gods and sorcerers―the story of how we overcame hunger, disease, ignorance, and squalor. I defy anyone to read this book and not feel better afterwards.

Lord Daniel Hannan, president of the Institute for Free Trade

The 65 fascinating stories in Heroes of Progress are
testaments to the ingenuity of humankind in delivering a richer,
healthier, and hopefully freer world. Alexander C. R. Hammond
provides an inspirational reminder that when individuals are
free to speak, think, innovate, and engage in open markets, the
heroic potential of humanity knows no bounds.

Lord Syed Kamall, Professor of politics and international relations, St. Mary’s University

In Heroes of Progress, Alexander Hammond reminds us that human minds are the fundamental driver of every discovery, invention, and innovation that has improved our lives. By telling the stories of pioneering men and women who have advanced civilization, this book not only honors past heroes of progress, but also provides inspiration for the next generation to use their uniquely human imaginative and enterprising capacities to build a better future.

— Clay Routledge, Vice President of Research and Director of the Human Flourishing Lab at the Archbridge Institute

NPR | Communicable Disease

A Drug to Prevent HIV, an “Unprecedented” Rollout

“Five months after a ‘breakthrough’ HIV prevention drug got approval in the United States and became available in many wealthy countries, it’s getting rolled out in two African countries hit especially hard by the disease.

On Wednesday, the U.S. State Department announced that Eswatini and Zambia have each received 500 doses of lenacapavir, a drug manufactured by Gilead Sciences that’s been hailed as by Science as a “breakthrough.” Just two injections a year provide near-complete protection against an HIV infection.

The delivered doses mark the first small step toward providing at least 2 million doses to the highest burden countries, largely in Africa, by 2028. That’s the goal of the Global Fund, a major donor to combating HIV, tuberculosis and malaria, along with Gilead Sciences and the State Department.”

From NPR.

Live Science | Communicable Disease

A “Functional Cure” for HIV May Be in Reach, Early Trials Suggest

“In 2025, researchers reported a breakthrough that suggests that a “functional” cure for HIV — a way to keep HIV under control long-term without constant treatment — may indeed be possible. In two independent trials using infusions of engineered antibodies, some participants remained healthy without taking antiretrovirals, long after the interventions ended.

In one of the trials — the FRESH trial, led by virologist Thumbi Ndung’u of the University of KwaZulu-Natal and the Africa Health Research Institute in South Africa — four of 20 participants maintained undetectable levels of HIV for a median of 1.5 years without taking antiretrovirals. In the other, the RIO trial set in the United Kingdom and Denmark and led by Sarah Fidler, a clinical doctor and HIV research expert at Imperial College London, six of 34 HIV-positive participants have maintained viral control for at least two years.

These landmark proof-of-concept trials show that the immune system can be harnessed to fight HIV. Researchers are now looking to conduct larger, more representative trials to see whether antibodies can be optimized to work for more people.”

From Live Science.

World Health Organization | Communicable Disease

African Countries’ Great Epidemiological Progress

“In the African region, 5 countries (Burkina Faso, Ghana, Mali, Niger and Zimbabwe) have already achieved the target for STH elimination and started preparing their dossiers with the support of the Expanded Special Project for Elimination of NTDs (ESPEN) at WHO regional office. For schistosomiasis, Egypt has already submitted to WHO its dossier of elimination of schistosomiasis as a public health problem and WHO has already set up a review committee to ascertain their evidence.

Regarding verification of interruption of transmission, the following countries have not been reporting autoch- thonous schistosomiasis cases for at least 10 years and are preparing dossiers for submission: Mauritius in the African region; Antigua and Barbuda, Dominican Republic, Guadeloupe, Martinique, Montserrat, Puerto Rico, Saint Lucia and Suriname in the region of the Americas; Djibouti, Iran (Islamic Republic of), Iraq, Jordan, Morocco and Tunisia in the Eastern Mediterra- nean region.”

From World Health Organization.

CTV News | Vaccination

Brazil Approves World’s First Single-Dose Dengue Vaccine

“Brazilian authorities on Wednesday approved the world’s first single-dose dengue vaccine, which they hailed as a ‘historic’ achievement as cases of the mosquito-borne disease soar globally due to rising temperatures.

Dengue, known for intense flu-like symptoms, crushing fatigue and body aches, reached record global levels in 2024 and researchers have attributed its spread to climate change.

Brazil’s health regulatory agency ANVISA authorized the use of Butantan-DV, developed by the Butantan Institute in São Paulo, for people aged 12 to 59.

Currently, the only dengue vaccine available worldwide is TAK-003, which requires two doses administered three months apart, according to the World Health Organization (WHO).

The single dose, developed after eight years of trials across Brazil, will allow for faster and simpler vaccination campaigns.”

From CTV News.